Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

dollar money graph increase finance

CMS finalizes 2024 MA payment rule with rate bump

According to CMS, MA plans will see an average payment increase of 3.32% from 2023 to 2024, worth approximately $13.8 billion in increases for next year.

FDA turns up sterility issues at eye drop facility linked to deaths, vision loss

The FDA has found a drug-resistant bacteria at an eye drop manufacturing facility linked to severe infections and even a few deaths.

Thumbnail

Affordable Care Act dealt a blow in new judgment

The Affordable Care Act (ACA) was dealt a major blow after a federal judge ruled that employers don’t have to cover certain preventive services, including PReP, which prevents HIV.

files paperwork work load

UnitedHealthcare to cut back on prior authorization paperwork

UnitedHealthcare announced it would remove 20% of its current prior authorizations starting with the third quarter of this year. 

 

pain pills opioids

FDA approves OTC Narcan for the first time

The medication can reverse an opioid overdose and is a critical, life-saving product now able to be sold directly to consumers in places like pharmacies, convenience stores, grocers, gas stations and online, the FDA said.

 

Congress aims to crack down on ‘zombie drug’

Xylazine is a sedative intended for animals such as horses and cattle, but it is increasingly being found mixed with strong opioids such as fentanyl.

A list of cardiovascular drugs a patient is taking in a graphical format in the Cardioviso atrial fibrillation patient management application GE Healthcare showed at ACC.23.#ACC23 #ACC

Lawsuit slams PBMs Cigna, Humana as price-fixing ‘modern gangsters’

“Medications shouldn’t cost an arm and a leg, metaphorically or literally,” says Ohio Attorney General Dave Yost “Insulin is just a symptom of the problem; PBMs are the disease.”

 

cardiologist doctor physician patient black diverse hypertension

Healthcare groups ask CMS to create hybrid primary care payment option

Twenty-seven healthcare organizations signed the letter to CMS asking the agency to create a hybrid payment model, including the National Association of Accountable Care Organizations, AMGA, the American Academy of Family Physicians and the Primary Care Collaborative.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.